| 1501 |
Bone Marrow |
Allogeneic |
Severe Combined Immunodeficiency |
Hematology |
2024 |
Standard Therapy |
Poland |
2 |
| 1502 |
Bone Marrow |
Allogeneic |
Severe Congenital Neutropenia |
Hematology |
2024 |
Standard Therapy |
Poland |
1 |
| 1503 |
Bone Marrow |
Allogeneic |
Shwachman-Diamond Syndrome |
Hematology |
2024 |
Standard Therapy |
Poland |
10 |
| 1504 |
Bone Marrow |
Allogeneic |
Sickle Cell Disease |
Hematology |
2024 |
Standard Therapy |
Poland |
9 |
| 1505 |
Bone Marrow |
Allogeneic |
Biphenotypic Acute Leukemia |
Hematology |
2024 |
Standard Therapy |
Ukraine |
10 |
| 1506 |
Bone Marrow |
Allogeneic |
Acute Myelogenous Leukemia |
Hematology |
2024 |
Standard Therapy |
Poland |
58 |
| 1507 |
Bone Marrow |
Allogeneic |
Acute Lymphoblastic Leukemia |
Hematology |
2024 |
Standard Therapy |
United Kingdom |
12 |
| 1508 |
Bone Marrow |
Allogeneic |
hemophagocytic lymphohistiocytosis |
Hematology |
2024 |
Standard Therapy |
Sweden |
4 months |
| 1509 |
Bone Marrow |
Allogeneic |
Severe combined immunodeficiency |
Hematology |
2024 |
Standard Therapy |
Germany |
1 |
| 1510 |
Bone Marrow |
Allogeneic |
Beta-Thalassemia Major |
Hematology |
2024 |
Standard Therapy |
India |
11 |
| 1511 |
Bone Marrow |
Allogeneic |
Acute Myelogenous Leukemia |
Hematology |
2024 |
Standard Therapy |
Austria |
4 |
| 1512 |
Bone Marrow |
Allogeneic |
Acute Myelogenous Leukemia |
Hematology |
2024 |
Standard Therapy |
Norway |
33 |
| 1513 |
Bone Marrow |
Allogeneic |
Acute Lymphoblastic Leukemia |
Hematology |
2024 |
Standard Therapy |
Spain |
16 |
| 1514 |
Bone Marrow |
Allogeneic |
Severe Aplastic Anemia |
Hematology |
2024 |
Standard Therapy |
Switzerland |
5 |
| 1515 |
Bone Marrow |
Allogeneic |
T- Acute Lymphoblastic Leukemia |
Hematology |
2024 |
Standard Therapy |
Ireland |
6 |
| 1516 |
Bone Marrow |
Allogeneic |
Myelodysplastic Syndrome |
Hematology |
2024 |
Standard Therapy |
Poland |
12 |
| 1517 |
Bone Marrow |
Allogeneic |
Severe Combined Immunodeficiency |
Hematology |
2024 |
Standard Therapy |
USA |
4 months |
| 1518 |
Bone Marrow |
Allogeneic |
Acute Myelogenous Leukemia |
Hematology |
2024 |
Standard Therapy |
Belgium |
50 |
| 1519 |
Bone Marrow |
Allogeneic |
Myelodysplastic Syndrome |
Hematology |
2024 |
Standard Therapy |
France |
31 |
| 1520 |
Bone Marrow |
Allogeneic |
Chronic myelomonocytic leukemia |
Hematology |
2024 |
Standard Therapy |
Italy |
64 |
| 1521 |
Bone Marrow |
Allogeneic |
Severe Aplastic Anemia |
Hematology |
2024 |
Standard Therapy |
France |
10 |
| 1522 |
Bone Marrow |
Allogeneic |
Severe Aplastic Anemia |
Hematology |
2024 |
Standard Therapy |
Poland |
12 |
| 1523 |
Bone Marrow |
Allogeneic |
Acute Lymphoblastic Leukemia |
Hematology |
2024 |
Standard Therapy |
USA |
4 |
| 1524 |
Bone Marrow |
Allogeneic |
Acute Lymphoblastic Leukemia |
Hematology |
2024 |
Standard Therapy |
Canada |
8 |
| 1525 |
Bone Marrow |
Allogeneic |
Severe Aplastic Anemia |
Hematology |
2024 |
Standard Therapy |
Poland |
17 |
| 1526 |
Bone Marrow |
Allogeneic |
Severe Aplastic Anemia |
Hematology |
2024 |
Standard Therapy |
USA |
8 |
| 1527 |
Bone Marrow |
Allogeneic |
Severe Aplastic Anemia |
Hematology |
2024 |
Standard Therapy |
USA |
67 |
| 1528 |
Bone Marrow |
Allogeneic |
Hodgkins Lymphoma |
Hematology |
2024 |
Standard Therapy |
United Kingdom |
36 |
| 1529 |
Bone Marrow |
Allogeneic |
Acute Myelogenous Leukemia |
Hematology |
2024 |
Standard Therapy |
USA |
72 |
| 1530 |
Bone Marrow |
Allogeneic |
Acute Myelogenous Leukemia |
Hematology |
2024 |
Standard Therapy |
USA |
9 |
| 1531 |
Bone Marrow |
Allogeneic |
Chronic Granulomatous Disease |
Hematology |
2024 |
Standard Therapy |
USA |
3 |
| 1532 |
Apheresis |
Allogeneic |
A- Thalassemia |
Hematology |
2024 |
Standard Therapy |
Poland |
11 |
| 1533 |
Apheresis |
Allogeneic |
Acute Lymphoblastic Leukemia |
Hematology |
2024 |
Standard Therapy |
Poland |
13 |
| 1534 |
Apheresis |
Allogeneic |
Acute Lymphoblastic Leukemia |
Hematology |
2024 |
Standard Therapy |
Poland |
21 |
| 1535 |
Apheresis |
Allogeneic |
Acute Lymphoblastic Leukemia |
Hematology |
2024 |
Standard Therapy |
Poland |
22 |
| 1536 |
Apheresis |
Allogeneic |
Acute Lymphoblastic Leukemia |
Hematology |
2024 |
Standard Therapy |
Poland |
38 |
| 1537 |
Apheresis |
Allogeneic |
Acute Lymphoblastic Leukemia |
Hematology |
2024 |
Standard Therapy |
Germany |
41 |
| 1538 |
Apheresis |
Allogeneic |
Acute Lymphoblastic Leukemia |
Hematology |
2024 |
Standard Therapy |
Poland |
44 |
| 1539 |
Apheresis |
Allogeneic |
Acute Lymphoblastic Leukemia |
Hematology |
2024 |
Standard Therapy |
Poland |
44 |
| 1540 |
Apheresis |
Allogeneic |
Acute Lymphoblastic Leukemia |
Hematology |
2024 |
Standard Therapy |
Poland |
48 |
| 1541 |
Apheresis |
Allogeneic |
Acute Lymphoblastic Leukemia |
Hematology |
2024 |
Standard Therapy |
Poland |
50 |
| 1542 |
Apheresis |
Allogeneic |
Acute Lymphoblastic Leukemia |
Hematology |
2024 |
Standard Therapy |
Germany |
50 |
| 1543 |
Apheresis |
Allogeneic |
Acute Lymphoblastic Leukemia |
Hematology |
2024 |
Standard Therapy |
Poland |
55 |
| 1544 |
Apheresis |
Allogeneic |
Acute Lymphoblastic Leukemia |
Hematology |
2024 |
Standard Therapy |
Poland |
59 |
| 1545 |
Apheresis |
Allogeneic |
Acute Lymphoblastic Leukemia |
Hematology |
2024 |
Standard Therapy |
Germany |
60 |
| 1546 |
Apheresis |
Allogeneic |
Acute Lymphoblastic Leukemia |
Hematology |
2024 |
Standard Therapy |
Poland |
63 |
| 1547 |
Apheresis |
Allogeneic |
Acute Lymphoblastic Leukemia |
Hematology |
2024 |
Standard Therapy |
Poland |
44 |
| 1548 |
Apheresis |
Allogeneic |
Acute Lymphoblastic Leukemia |
Hematology |
2024 |
Standard Therapy |
Poland |
59 |
| 1549 |
Apheresis |
Allogeneic |
Acute Lymphoblastic Leukemia |
Hematology |
2024 |
Standard Therapy |
Poland |
51 |
| 1550 |
Apheresis |
Allogeneic |
Acute Lymphoblastic Leukemia |
Hematology |
2024 |
Standard Therapy |
Poland |
34 |
| 1551 |
Apheresis |
Allogeneic |
Acute Myelogenous Leukemia |
Hematology |
2024 |
Standard Therapy |
Poland |
1 |
| 1552 |
Apheresis |
Allogeneic |
Acute Myelogenous Leukemia |
Hematology |
2024 |
Standard Therapy |
Poland |
10 |
| 1553 |
Apheresis |
Allogeneic |
Acute Myelogenous Leukemia |
Hematology |
2024 |
Standard Therapy |
Poland |
20 |
| 1554 |
Apheresis |
Allogeneic |
Acute Myelogenous Leukemia |
Hematology |
2024 |
Standard Therapy |
Poland |
25 |
| 1555 |
Apheresis |
Allogeneic |
Acute Myelogenous Leukemia |
Hematology |
2024 |
Standard Therapy |
Poland |
26 |
| 1556 |
Apheresis |
Allogeneic |
Acute Myelogenous Leukemia |
Hematology |
2024 |
Standard Therapy |
Poland |
28 |
| 1557 |
Apheresis |
Allogeneic |
Acute Myelogenous Leukemia |
Hematology |
2024 |
Standard Therapy |
Poland |
34 |
| 1558 |
Apheresis |
Allogeneic |
Acute Myelogenous Leukemia |
Hematology |
2024 |
Standard Therapy |
Poland |
35 |
| 1559 |
Apheresis |
Allogeneic |
Acute Myelogenous Leukemia |
Hematology |
2024 |
Standard Therapy |
Poland |
37 |
| 1560 |
Apheresis |
Allogeneic |
Acute Myelogenous Leukemia |
Hematology |
2024 |
Standard Therapy |
Poland |
38 |
| 1561 |
Apheresis |
Allogeneic |
Acute Myelogenous Leukemia |
Hematology |
2024 |
Standard Therapy |
Poland |
38 |
| 1562 |
Apheresis |
Allogeneic |
Acute Myelogenous Leukemia |
Hematology |
2024 |
Standard Therapy |
Poland |
40 |
| 1563 |
Apheresis |
Allogeneic |
Acute Myelogenous Leukemia |
Hematology |
2024 |
Standard Therapy |
Poland |
41 |
| 1564 |
Apheresis |
Allogeneic |
Acute Myelogenous Leukemia |
Hematology |
2024 |
Standard Therapy |
Poland |
43 |
| 1565 |
Apheresis |
Allogeneic |
Acute Myelogenous Leukemia |
Hematology |
2024 |
Standard Therapy |
Poland |
51 |
| 1566 |
Apheresis |
Allogeneic |
Acute Myelogenous Leukemia |
Hematology |
2024 |
Standard Therapy |
Poland |
51 |
| 1567 |
Apheresis |
Allogeneic |
Acute Myelogenous Leukemia |
Hematology |
2024 |
Standard Therapy |
Poland |
51 |
| 1568 |
Apheresis |
Allogeneic |
Acute Myelogenous Leukemia |
Hematology |
2024 |
Standard Therapy |
Poland |
59 |
| 1569 |
Apheresis |
Allogeneic |
Acute Myelogenous Leukemia |
Hematology |
2024 |
Standard Therapy |
Poland |
59 |
| 1570 |
Apheresis |
Allogeneic |
Acute Myelogenous Leukemia |
Hematology |
2024 |
Standard Therapy |
Poland |
60 |
| 1571 |
Apheresis |
Allogeneic |
Acute Myelogenous Leukemia |
Hematology |
2024 |
Standard Therapy |
Poland |
60 |
| 1572 |
Apheresis |
Allogeneic |
Acute Myelogenous Leukemia |
Hematology |
2024 |
Standard Therapy |
Poland |
60 |
| 1573 |
Apheresis |
Allogeneic |
Acute Myelogenous Leukemia |
Hematology |
2024 |
Standard Therapy |
Poland |
61 |
| 1574 |
Apheresis |
Allogeneic |
Acute Myelogenous Leukemia |
Hematology |
2024 |
Standard Therapy |
Poland |
61 |
| 1575 |
Apheresis |
Allogeneic |
Acute Myelogenous Leukemia |
Hematology |
2024 |
Standard Therapy |
Poland |
62 |
| 1576 |
Apheresis |
Allogeneic |
Acute Myelogenous Leukemia |
Hematology |
2024 |
Standard Therapy |
Poland |
62 |
| 1577 |
Apheresis |
Allogeneic |
Acute Myelogenous Leukemia |
Hematology |
2024 |
Standard Therapy |
Poland |
64 |
| 1578 |
Apheresis |
Allogeneic |
Acute Myelogenous Leukemia |
Hematology |
2024 |
Standard Therapy |
Poland |
65 |
| 1579 |
Apheresis |
Allogeneic |
Acute Myelogenous Leukemia |
Hematology |
2024 |
Standard Therapy |
Poland |
66 |
| 1580 |
Apheresis |
Allogeneic |
Acute Myelogenous Leukemia |
Hematology |
2024 |
Standard Therapy |
Poland |
67 |
| 1581 |
Apheresis |
Allogeneic |
Acute Myelogenous Leukemia |
Hematology |
2024 |
Standard Therapy |
Poland |
67 |
| 1582 |
Apheresis |
Allogeneic |
Acute Myelogenous Leukemia |
Hematology |
2024 |
Standard Therapy |
Poland |
68 |
| 1583 |
Apheresis |
Allogeneic |
Acute Myelogenous Leukemia |
Hematology |
2024 |
Standard Therapy |
Poland |
69 |
| 1584 |
Apheresis |
Allogeneic |
Acute Myelogenous Leukemia |
Hematology |
2024 |
Standard Therapy |
Poland |
69 |
| 1585 |
Apheresis |
Allogeneic |
Acute Myelogenous Leukemia |
Hematology |
2024 |
Standard Therapy |
Poland |
69 |
| 1586 |
Apheresis |
Allogeneic |
Acute Myelogenous Leukemia |
Hematology |
2024 |
Standard Therapy |
Poland |
69 |
| 1587 |
Apheresis |
Allogeneic |
Acute Myelogenous Leukemia |
Hematology |
2024 |
Standard Therapy |
Poland |
69 |
| 1588 |
Apheresis |
Allogeneic |
Acute Myelogenous Leukemia |
Hematology |
2024 |
Standard Therapy |
Poland |
70 |
| 1589 |
Apheresis |
Allogeneic |
Acute Myelogenous Leukemia |
Hematology |
2024 |
Standard Therapy |
Poland |
70 |
| 1590 |
Apheresis |
Allogeneic |
Acute Myelogenous Leukemia |
Hematology |
2024 |
Standard Therapy |
Poland |
72 |
| 1591 |
Apheresis |
Allogeneic |
Acute Myelogenous Leukemia |
Hematology |
2024 |
Standard Therapy |
Poland |
73 |
| 1592 |
Apheresis |
Allogeneic |
Acute Myelogenous Leukemia |
Hematology |
2024 |
Standard Therapy |
Poland |
77 |
| 1593 |
Apheresis |
Allogeneic |
Acute Myelogenous Leukemia |
Hematology |
2024 |
Standard Therapy |
Poland |
59 |
| 1594 |
Apheresis |
Allogeneic |
Acute Myelogenous Leukemia |
Hematology |
2024 |
Standard Therapy |
Poland |
66 |
| 1595 |
Apheresis |
Allogeneic |
Acute Myelogenous Leukemia |
Hematology |
2024 |
Standard Therapy |
Poland |
58 |
| 1596 |
Apheresis |
Allogeneic |
Acute Myelogenous Leukemia |
Hematology |
2024 |
Standard Therapy |
Poland |
54 |
| 1597 |
Apheresis |
Allogeneic |
Acute Myelogenous Leukemia |
Hematology |
2024 |
Standard Therapy |
Poland |
29 |
| 1598 |
Apheresis |
Allogeneic |
Acute Myelogenous Leukemia |
Hematology |
2024 |
Standard Therapy |
Poland |
64 |
| 1599 |
Apheresis |
Allogeneic |
Acute Myelogenous Leukemia |
Hematology |
2024 |
Standard Therapy |
Poland |
27 |
| 1600 |
Apheresis |
Allogeneic |
Acute Myelogenous Leukemia |
Hematology |
2024 |
Standard Therapy |
Poland |
60 |